CTIS newsflash - 10 September 2024
Submitted by Anonymous (not verified) on 10 September 2024 - 10:26
CTIS newsflash - 10 September 2024
Membership list: HMA-EMA joint Big Data Steering Group
Submitted by Anonymous (not verified) on 10 September 2024 - 10:20
Membership list: HMA-EMA joint Big Data Steering Group
Human medicines European public assessment report (EPAR): Nyxthracis (previously Obiltoxaximab SFL), obiltoxaximab, Date of authorisation: 18/11/2020, Revision: 3, Status: Withdrawn (authorisation)
Submitted by Anonymous (not verified) on 9 September 2024 - 16:02
Human medicines European public assessment report (EPAR): Nyxthracis (previously Obiltoxaximab SFL), obiltoxaximab, Date of authorisation: 18/11/2020, Revision: 3, Status: Withdrawn (authorisation)
Questions and answers - Info session on web-based electronic Application Form (eAF) add package
Submitted by Anonymous (not verified) on 9 September 2024 - 15:27
Questions and answers - Info session on web-based electronic Application Form (eAF) add package
Member states contact points for translations review
Submitted by Anonymous (not verified) on 9 September 2024 - 15:23
Member states contact points for translations review
Agenda of the CVMP meeting 10-12 September 2024
Submitted by Anonymous (not verified) on 9 September 2024 - 14:10
Agenda of the CVMP meeting 10-12 September 2024
Veterinary pre-submission meeting request form - in accordance with Regulation (EU) No 2019/6
Submitted by Anonymous (not verified) on 9 September 2024 - 10:21
Veterinary pre-submission meeting request form - in accordance with Regulation (EU) No 2019/6
Early Career Webinar: Challenges during medical career, a perspective on our mental health
Submitted by Aneta on 9 September 2024 - 10:15
Dear Colleagues,
Committee for Advanced Therapies (CAT): 11-12 September 2024, European Medicines Agency, Amsterdam, the Netherlands, from 11 September 2024 to 12 September 2024
Submitted by Anonymous (not verified) on 9 September 2024 - 9:55
Committee for Advanced Therapies (CAT): 11-12 September 2024, European Medicines Agency, Amsterdam, the Netherlands, from 11 September 2024 to 12 September 2024
Clinical development of medicinal products for the treatment and prevention of bipolar disorder
Submitted by Anonymous (not verified) on 9 September 2024 - 8:40
Clinical development of medicinal products for the treatment and prevention of bipolar disorder